HRTX
Heron Therapeutics Inc
Price:  
2.00 
USD
Volume:  
1,096,766.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRTX Relative Valuation

-148.9%
Upside

As of 2025-06-19, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (0.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.00 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -148.9%.

The range of the Relative Valuation is (0.82) - (1.22) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 16.1x - 24.4x 21.7x
Forward P/E multiples 14.3x - 23.9x 16.6x
Fair Price (0.82) - (1.22) (0.98)
Upside -141.0% - -161.0% -148.9%
2.00 USD
Stock Price
(0.98) USD
Fair Price

HRTX Relative Valuation - Historical P/E Data

Date P/E
2025-06-09 -41.54
2025-06-06 -41.15
2025-06-05 -39.19
2025-06-04 -39.98
2025-06-03 -39.19
2025-06-02 -37.82
2025-05-30 -36.84
2025-05-29 -37.43
2025-05-28 -35.86
2025-05-27 -37.04
2025-05-23 -36.25
2025-05-22 -36.65
2025-05-21 -36.84
2025-05-20 -37.63
2025-05-19 -37.63
2025-05-16 -38.61
2025-05-15 -36.65
2025-05-14 -33.71
2025-05-13 -36.06
2025-05-12 -40.17
2025-05-09 -41.35
2025-05-08 -42.52
2025-05-07 -44.29
2025-05-06 -47.42
2025-05-05 -41.74
2025-05-02 -45.27
2025-05-01 -46.05
2025-04-30 -47.42
2025-04-29 -45.86
2025-04-28 -45.66
2025-04-25 -45.07
2025-04-24 -44.48
2025-04-23 -43.11
2025-04-22 -42.13
2025-04-21 -37.82
2025-04-17 -36.06
2025-04-16 -36.06
2025-04-15 -37.63
2025-04-14 -37.82
2025-04-11 -37.43
2025-04-10 -35.67
2025-04-09 -36.84
2025-04-08 -34.69
2025-04-07 -38.41
2025-04-04 -41.15
2025-04-03 -41.94
2025-04-02 -43.70
2025-04-01 -41.35
2025-03-31 -43.11
2025-03-28 -44.29